SEPTEMBER 2023LIFE SCIENCES REVIEW5Stefano Baila,Managing Director support Biologics, EurofinsThe Revolutionary Power of Cell and Gene TherapiesIN MY OPINION08CXO INSIGHTSLAST WORD17JAMES RIDDLE,MCSE, CIP, CPIA, CRQM, Vice President,Research Services & Strategic Consulting,AdvarraExpanding the Promise of Immunotherapy Beyond the Oncology Realm22James Holland,PhD. Senior Medical Writer,Ashfield HealthKindiya Geghman,PhD, CMPP. Vice President Medical & Scientific Services,Ashfield HealthImmunotherapy in Lung Cancer: building towards a patient-tailored future20Anita Nelsen,Senior Vice President, Clinical Trial Operations,AllucentPatient-Centric Approach to Accele rating Clinical Trials26 Safwan Kezbor,Medical Director, Clinical Development,Shionogi Inc.Accelerating Early-stage Drug Development28Steven Henck,Ph.D., Vice President of R&D,Integrated DNA TechnologiesImproving Minimal Residual Disease Detection Using NGS30Immunotherapy: Unleashing the Power of the Immune System in Cancer TreatmentClement Lim,Associate Director, Head of Early Cancer Detection,Scientific & Medical Affairs,Mirxes
< Page 4 | Page 6 >